Pirin Antikörper (AA 1-290)
-
- Target Alle Pirin (PIR) Antikörper anzeigen
- Pirin (PIR)
-
Bindungsspezifität
- AA 1-290
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Pirin Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Pirin protein (1-290AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- Pirin (PIR)
- Andere Bezeichnung
- PIR (PIR Produkte)
- Synonyme
- ATPIRIN1 antikoerper, PRN1 antikoerper, pirin antikoerper, 2310042L19Rik antikoerper, Pirnl antikoerper, zgc:92778 antikoerper, xpir antikoerper, pirin antikoerper, pirin L homeolog antikoerper, PIR antikoerper, PRN antikoerper, Pir antikoerper, pir antikoerper, pir.L antikoerper
- Hintergrund
-
Background: Transcriptional coregulator of NF-kappa-B which facilitates binding of NF-kappa-B proteins to target kappa-B genes in a redox-state-dependent manner. May be required for efficient terminal myeloid maturation of hematopoietic cells. Has quercetin 2,3-dioxygenase activity (in vitro).
Aliases: 3-dioxygenase PIR antibody, Iron binding nuclear protein antibody, Pir antibody, PIR_HUMAN antibody, Pirin antibody, Probable quercetin 2 antibody, probable quercetin 2,3-dioxygenase PIR antibody, Probable quercetinase antibody
- UniProt
- O00625
-